Radiation Dermatitis Treatment Market is Likely to Reach a Value of around US$ 700 million by 2031

Fact.MR’s recent report on the global radiation dermatitis treatment market forecasts a healthy growth pace, expecting a revenue share of nearly US$ 700 million by 2031, with an estimated CAGR of around 5% throughout the 2021-2031 forecast period. Increased frequency of radiation-based cancer treatment is attributed to be the chief growth driver for this market.

Click HERE to Get Complete Synopsis of the Report- https://www.factmr.com/report/radiation-dermatitis-treatment-market

According to the report, the market accrued significant past gains, reaching around US$ 400 million in value as of 2019. Growth is especially forecast to remain strongest across Asia Pacific, with countries such as China and India emerging at the forefront amid swift advancements in oncology. Approaches such as Traditional Chinese Medicine (TCM) are grabbing major eyeballs.

“Multiple wound care and management practices are spurring innovations in the radiation dermatitis treatment domain, prompting key market players to introduce highly novel therapeutic approaches, widening growth prospects,” says a Fact.MR analyst.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=6102

Manufacturers are investing in a slew of innovative treatment approaches, including the introduction of film-forming gels. For instance, Switzerland-based Stratpharma has introduced its StrataXRT­­® film-forming wound dressing gel that easily spreads across the affected site in minimal quantities. StrataXRT film-forming gel dries as a thin, flexible, and protective layer, which is gas permeable, waterproof, inert, and devoid of any measurable pH value. The formulation promotes a moist wound healing environment. Companies are taking cues from such developments to manufacture film-forming gels that provide symptomatic relief from acute inflammatory response, discomfort, and itching.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=6102

Key Takeaways from Market Study

By product, demand for topical hydrophilic creams expected to incline massively through 2031

Topical corticosteroid medications to witness impressive uptake over coming years

By distribution channel, retail pharmacies to remain dominant, online pharmacies surging in popularity

The U.S. to emerge as a potentially lucrative market amid high skin cancer prevalence and treatment rates

India to emerge as a promising market for radiation dermatitis treatment in future
High adoption of Traditional Chinese Medicine (TCM) to elevate China’s growth prospects

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/6102/S

Competitive Landscape

Prominent radiation dermatitis treatment players include 3M Company, Molnlycke Health Care AB, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTech Group Plc, and BMG PHARMA S.p.A, among others. Major expansion strategies involve new product launches, acquisitions, and collaborations.

In February 2020, Integra Lifesciences launched the AminoExcel® Plus Placental Allograft Membrane, an advanced wound care offering to support soft tissue repair. AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds.

In January 2020, ConvaTech Group released the ConvaMaxTM superabsorber wound dressing used for the management of highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers and dehisced surgical wounds. The product helps manage excess moisture to help protect skin integrity, available in silicone adhesive and non-adhesive forms.

For More Insights: https://www.prnewswire.com/news-releases/focus-on-early-detection-boosts-cervical-dysplasia-diagnostics-adoption-factmr-301233468.html

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the radiation dermatitis treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (oral medication, topical, and dressings) and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies) across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.